NEW YORK, NY, Oct. 30, 2023 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ:BIMI, "BIMI")), a healthcare products and services provider today announced that its subsidiary, Phenix Bio Inc., appointed Hao Mu Pte. Ltd., a Singapore company ("Hao Mu"), as a distributor responsible for the distribution of Phenix's 17 herbal supplements in Mainland China.
Pursuant to the terms of a sales agreement entered into on October 29, 2023, Hao Mu must make annual purchases of at least $5 million in order to maintain its distributor status for this territory.
Under the terms of this agreement, Phenix's comprehensive portfolio of high-quality herbal supplements will be made available to consumers in Mainland China through Hao Mu's well-established ...